Acalabrutinib FDA approval date

The FDA approved Acalabrutinib on 31 Oct 2017.

FDA approval date
31 Oct 2017

Drug identity checked against registry records

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-10-31DayAcalabrutinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210259", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["CALQUENCE"], "active_ingredients": ["ACALABRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20171031", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026